Company: SMNR
Filing Date: 2025-12-03
Form Type: S-8
Source: 0001193125-25-306962
Chunk: 15

Company: Semnur Pharmaceuticals, Inc.
Filing Date: 2025-12-03
Form: S-8
Chunk 15
---
 grant date of 
 August 30, 2024, subject to the Dr. Ji’s continued service (as defined in the Plan) through each vesting date.                                                                                                                             |

| (7) | Consists of 2,500,000 shares of Common Stock issuable upon exercise of a stock option granted to Mr. Ma                                                                                             
 pursuant to the Plan, of which 833,333 shares of Common Stock are exercisable within 60 days of the Determination Date, whereby 1/48th of the total amount of the shares vested and shall vest each 
 month after the option grant date of August 30, 2024, subject to the Mr. Ma’s continued service (as defined in the Plan) through each vesting date.                                                 |

Other Material Relationships with the Selling Stockholders Employment Agreements The Company entered into employment agreements with each of Mr. Shah, Dr. Ji and Mr. Ma, effective as of the closing of the Business Combination (collectively, the “Employment Agreements”). Pursuant to the employment agreement entered into with Mr. Shah, Mr. Shah will serve as the Chief Executive Officer and President of the Company. Mr. Shah’s annualized salary will be $1,250,000 and he will be eligible to receive an annual incentive bonus of up to 150% of his base salary. The Compensation Committee of the Board (the “Compensation Committee”) shall annually review and adjust his base salary. Pursuant to the employment agreement entered into with Dr. Ji, Dr. Ji will serve as the Executive Chairperson of the Company. Dr. Ji’s annualized salary will be $1,100,000 and he will be eligible to receive an annual incentive bonus of up to 150% of his base salary. The Compensation Committee shall annually review and adjust his base salary. Pursuant to the employment agreement entered into with Mr. Ma, Mr. Ma will serve as the Chief Financial Officer, Senior Vice President and Secretary of the Company. Mr. Ma’s annualized salary will be $345,000 and he will be eligible to receive an annual incentive bonus of up to 60% of his base salary. The Compensation Committee shall annually review and adjust his base salary. Each Employment Agreement has a term of three years and will renew automatically for additional one year terms, unless either party provides the other with written notice of non-renewalat least 60 days prior to the date of automatic renewal. Each executive officer’s employment will be on an “at will” basis